AI for Social Good Platform

ElohaX is an AI-driven platform committed to harnessing AI for Social Good, with applications spanning health, environment, and energy.

Core Initiative

AI-driven Drug Discovery for human diseases, with a present focus on Alzheimer’s Disease (AD).

Present Focus

Our flagship initiative, DeepDrug^X, is dedicated to accelerating the discovery of therapies for Alzheimer’s Disease. By combining AI-driven drug discovery with neurogenetic insights, we are tackling one of the most urgent challenges in global health: finding effective treatments for neurodegeneration.

Scientific Collaboration

We partner with one of the world’s leading expert, Professor David Rubinsztein (Cambridge Neurogenetics) on neurodegeneration, integrating cutting-edge genetic research with AI-powered drug discovery to ensure DeepDrug^X is both scientifically rigorous and clinically impactful.

Advisory Leadership

Mrs. Ingrid Kwok serves as the Chair of the Advisory Board. Ingrid provides strategic guidance and governance, ensuring that our AD-focused innovations are embedded in a framework of sustainability and long-term social impact.

Academic Recognition

Our work has been honored with the prestigious National Academy of Medicine (NAM) Healthy Longevity Catalyst Awards (HLCA) on four occasions, making us the only team in Hong Kong to achieve this distinction. This recognition underscores our mark of excellence, innovation, and social relevance in bold interdisciplinary medical research.

About Co-Founders

Prof. Victor Li (Founder) is MIT-trained, formerly holding chair professorships at USC and HKU in Information Engineering, currently Director of HKU-AI WiSe. His entrepreneurial strategy empowers global scaling, using DeepDrug^X to accelerate drug discovery. Prof. Jacqueline Lam (Co-Founder) is Co-Director of HKU-AI WiSe, currently holding visiting academic positions at Cambridge and MIT. She is good at winning prestigious research grants, and mobilizing top universities to foster interdisciplinary collaboration in energy, environment and health. She advocates the mandate to use AI only for Social Good, ensuring every initiative aligns with ethical and societal stewardship.

Team Profile

Interdisciplinary team combining AI innovation, biomedical science, clinical validation, and commercialization expertise

Long-term research collaborations with local and international universities:

Pictures of the ElohaX Team (with Prof. Victor Li, Co-founder, Prof. Jacqueline Lam, Co-founder, and Mrs. Ingrid Kwok, Chair of Advisory Board)